David J. Adelstein

18.8k citations

257 papers · 10.2k indexed · 2 hit papers · h-index 51

Impact in

Otorhinolaryngology top 0.02%
- Head and Neck Cancer Studies
Pulmonary and Respiratory Medicine top 0.2%
- Gastric Cancer Management and Outcomes
- Oral health in cancer treatment
- Lung Cancer Treatments and Mutations

Papers in

Otorhinolaryngology 136
- Head and Neck Cancer Studies 134
Pulmonary and Respiratory Medicine 116
- Gastric Cancer Management and Outcomes 42
- Lung Cancer Treatments and Mutations 40
- Lung Cancer Diagnosis and Treatment 26

Co-authors: Pierre Lavertu Lisa Rybicki Jerrold P. Saxton Arlene A. Forastiere Thomas W. Rice David E. Schuller John F. Ensley Benjamin G. Wood
Journals: Journal of Clinical Oncology (41 papers)International Journal of Radiation Oncology*Biology*Physics (28 papers)Cancer (21 papers)Head & Neck (20 papers)Journal of Thoracic and Cardiovascular Surgery (11 papers)
Partner nations: United States Australia Canada

In The Last Decade

David J. Adelstein

250 papers receiving 9.9k citations

Hit Papers

align trajectories log scale

An Intergroup Phase III Comparison of Standard Radiation Therapy and Two Schedules of Concurrent Chemoradiotherapy in Patients With Unresectable Squamous Cell Head and Neck Cancer 2002 · 1.3k citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2002 Journal of Clinical Oncology
1998 New England Journal of Medicine

Peers

Countries citing papers authored by David J. Adelstein

Since Specialization

Citations

This map shows the geographic impact of David J. Adelstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David J. Adelstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David J. Adelstein more than expected).

Fields of papers citing papers by David J. Adelstein

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David J. Adelstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David J. Adelstein. The network helps show where David J. Adelstein may publish in the future.

Co-authors

The 25 scholars most cited alongside David J. Adelstein, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with David J. Adelstein Line = papers co-authored together David J. Adelstein links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Rethinking the 10‐pack‐year rule for favorable human papillomavirus–associated oropharynx carcinoma: A multi‐institution analysis Cancer ·James R. Broughman, David D. Xiong, Benjamin J. Moeller, Kevin J. Contrera, B. Prendes, Eric Lamarre, Jamie A. Ku, Brian B. Burkey, N.M. Woody, Nikhil Joshi, David J. Adelstein, J.L. Geiger, Catherine H. Frenkel, Zvonimir L. Milas, Daniel Brickman, Ashley Sumrall, Daniel R. Carrizosa, J.F. Greskovich, Shlomo A. Koyfman, Matthew C. Ward	2020	10
2	Impact of routine surveillance imaging on detecting recurrence in human papillomavirus associated oropharyngeal cancer Oral Oncology ·Joycelin Canavan, B.A. Harr, Joanna Bodmann, C.A. Reddy, J. Ferrini, Denise I. Ives, Deborah J. Chute, Christopher W. Fleming, N.M. Woody, J.L. Geiger, Nikhil Joshi, Shlomo A. Koyfman, David J. Adelstein	2020	7
3	Tumor Volume Useful Beyond Classic Criteria in Selecting Larynx Cancers For Preservation Therapy The Laryngoscope ·Jonathan Sharrett, Matthew C. Ward, Eric Murray, Joseph Scharpf, Eric Lamarre, B. Prendes, Robert R. Lorenz, Brian B. Burkey, Shlomo A. Koyfman, N.M. Woody, J.F. Greskovich, David J. Adelstein, J.L. Geiger, Nikhil Joshi	2019	6
4	Validating the AJCC 8th Edition of the Oral Cavity Cancer Staging System: A Multi-institutional Collaborative Study International Journal of Radiation OncologyBiologyPhysics ·Shlomo A. Koyfman, Nikhil Joshi, Eric Lamarre, C. Jillian Tsai, M.A. Schymick, H. Liu, Laura Tam, Lisa Rybicki, Neal Dunlap, Sandro Porceddu, A.I. Ghanem, Farzan Siddiqui, Jimmy J. Caudell, N. Lee, J.L. Geiger, Brian B. Burkey, David J. Adelstein, N.M. Woody	2018	3
5	Increased pathologic upstaging with rising time to treatment initiation for head and neck cancer: A mechanism for increased mortality Cancer ·Roy Xiao, Matthew C. Ward, Kailin Yang, David J. Adelstein, Shlomo A. Koyfman, B. Prendes, Brian B. Burkey	2018	50
6	Clinicopathologic features and treatment outcomes of patients with human epidermal growth factor receptor 2-positive adenocarcinoma of the esophagus and gastroesophageal junction Diseases of the Esophagus ·Brooke Phillips, Raymond R. Tubbs, Thomas W. Rice, Lisa Rybicki, Thomas Plesec, Cristina P. Rodriguez, Gregory M.M. Videtic, Jerrold P. Saxton, Denise I. Ives, David J. Adelstein	2012	18
7	Impact of preepiglottic space tumor involvement on concurrent chemoradiation therapy American Journal of Otolaryngology ·Walter T. Lee, Mark D. Rizzi, Joseph Scharpf, Robert R. Lorenz, Jerrod P. Saxton, David J. Adelstein, Ramon M. Esclamado	2009	2
8	Extent of neck dissection required after concurrent chemoradiation for stage IV head and neck squamous cell carcinoma Head & Neck ·Steven B. Cannady, Walter T. Lee, Joseph Scharpf, Robert R. Lorenz, Benjamin G. Wood, Marshall Strome, Pierre Lavertu, Ramon M. Esclamado, Jerrold P. Saxton, David J. Adelstein	2009	18
9	Head and neck squamous cell cancer and the human papillomavirus: Summary of a National Cancer Institute State of the Science Meeting, November 9–10, 2008, Washington, D.C. Head & Neck ·David J. Adelstein, John A. Ridge, Maura L. Gillison, Anil K. Chaturvedi, Gypsyamber DʼSouza, Patti E. Gravitt, William H. Westra, Amanda Psyrri, W. Martin Kast, Laura A. Koutsky, Anna R. Giuliano, Steven H. Krosnick, Andy Trotti, David E. Schuller, Arlene A. Forastiere, Claudio Dansky Ullmann	2009	211
10	A Phase II Trial of Accelerated Multimodality Therapy for Locoregionally Advanced Cancer of the Esophagus and Gastroesophageal Junction American Journal of Clinical Oncology ·David J. Adelstein, Thomas W. Rice, Lisa Rybicki, Jerrold P. Saxton, Gregory M.M. Videtic, Sudish C. Murthy, Gregory Zuccaro, John J. Vargo, John A. Dumot, M. A. Carroll	2007	16
11	Impact of Induction Concurrent Chemoradiotherapy on Pulmonary Function and Postoperative Acute Respiratory Complications in Esophageal Cancer CHEST Journal ·Rony M. Abou-Jawde, Tarek Mekhail, David J. Adelstein, Lisa Rybicki, Peter J. Mazzone, Marjorie A. Caroll, Thomas W. Rice	2005	56
12	Role of clinically determined depth of tumor invasion in the treatment of esophageal carcinoma Journal of Thoracic and Cardiovascular Surgery ·Thomas W. Rice, Eugene H. Blackstone, David J. Adelstein, Gregory Zuccaro, John J. Vargo, John R. Goldblum, Sudish C. Murthy, Malcolm M. DeCamp, Lisa Rybicki	2003	53
13	Refining esophageal cancer staging Journal of Thoracic and Cardiovascular Surgery ·Thomas W. Rice, Eugene H. Blackstone, Lisa Rybicki, David J. Adelstein, Sudish C. Murthy, Malcolm M. DeCamp, John R. Goldblum	2003	122
14	Value of accelerated multimodality therapy in stage IIIA and IIIB non–small cell lung cancer Journal of Thoracic and Cardiovascular Surgery ·Malcolm M. DeCamp, Thomas W. Rice, David J. Adelstein, Mark A. Chidel, Lisa Rybicki, Sudish C. Murthy, Eugene H. Blackstone	2003	29
15	Stage III non–small cell lung cancer and metachronous brain metastases Journal of Thoracic and Cardiovascular Surgery ·Nader Moazami, Thomas W. Rice, Lisa Rybicki, David J. Adelstein, Sudish C. Murthy, Malcolm M. DeCamp, Gene H. Barnett, Mark A. Chidel, John H. Suh, Eugene H. Blackstone	2002	35
16	N1 esophageal carcinoma: The importance of staging and downstaging Journal of Thoracic and Cardiovascular Surgery ·Thomas W. Rice, Eugene H. Blackstone, David J. Adelstein, Gregory Zuccaro, John J. Vargo, John R. Goldblum, Lisa Rybicki, Sudish C. Murthy, Malcolm M. DeCamp	2001	63
17	INDUCTION CHEMOTHERAPY IN HEAD AND NECK CANCER Hematology/Oncology Clinics of North America ·David J. Adelstein	1999	27
18	Aggressive multimodality therapy for malignant pleural mesothelioma The Annals of Thoracic Surgery ·Thomas W. Rice, David J. Adelstein, Thomas J. Kirby, Matthew G. Saltarelli, Siva R. Murthy, Marjorie A. Van Kirk, Herbert Wiedemann, James K. Weick	1994	49
19	Efficacy of high-dose oral leucovorin and 5-fluorouracil in advanced colorectal carcinoma. Plasma and tissue pharmacokinetics Cancer ·John Hines, David J. Adelstein, Jeffrey L. Spiess, Paul Giroski, Susan Gear Carter	1989	21
20	Chemoradiotherapy as initial management in patients with squamous cell carcinoma of the head and neck. PubMed ·David J. Adelstein, Vishwa M. Sharan, Alison Earle, Ajit C. Shah, Catherine Vlastou, Chandra D. Haria, S. G. Carter, Catherine Damm, John Hines	1986	12

About David J. Adelstein

David J. Adelstein is a scholar working on Otorhinolaryngology, Pulmonary and Respiratory Medicine, Oncology, Surgery and Speech and Hearing, having authored 257 papers that have together received 10.2k indexed citations. Recurring topics across this work include Head and Neck Cancer Studies (134 papers), Esophageal Cancer Research and Treatment (56 papers), Head and Neck Surgical Oncology (55 papers), Gastric Cancer Management and Outcomes (42 papers), Lung Cancer Treatments and Mutations (40 papers), Cancer Diagnosis and Treatment (29 papers), Esophageal and GI Pathology (26 papers) and Lung Cancer Diagnosis and Treatment (26 papers). The work is most often cited by research in Otorhinolaryngology (5.1k citations), Pulmonary and Respiratory Medicine (4.6k citations), Oncology (3.3k citations), Surgery (5.0k citations) and Speech and Hearing (691 citations). David J. Adelstein has collaborated with scholars based in United States, Australia and Canada. Frequent co-authors include Pierre Lavertu, Lisa Rybicki, Jerrold P. Saxton, Arlene A. Forastiere, Thomas W. Rice, David E. Schuller, John F. Ensley, Benjamin G. Wood, George L. Adams and Henry Wagner. Their work appears in journals such as Journal of Clinical Oncology, International Journal of Radiation Oncology*Biology*Physics, Cancer, Head & Neck and Journal of Thoracic and Cardiovascular Surgery.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact